TRIM28 and breast carcinoma: Importantly, the formation of BORG:TRIM28 complexes was sufficient to drive latent disseminated breast cancer cells to reactivate proliferative programs coupled to disease recurrence, thereby establishing BORG, TRIM28, and their downstream effectors as clinically relevant targets to alleviate breast cancer metastasis.